Safety and Effectiveness of Gemcitabine in 855 Patients with Pancreatic Cancer under Japanese Clinical Practice Based on Post-marketing Surveillance in Japan

Author： Ioka Tatsuya   Katayama Kazuhiro   Tanaka Sachiko   Takakura Rena   Ashida Reiko   Kobayashi Noriko   Taniai Hisashi  

Publisher： Oxford University Press

ISSN： 1465-3621

Source： Japanese Journal of Clinical Oncology, Vol.43, Iss.2, 2013-02, pp. : 139-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan

By Horiuchi-Yamamoto Yuka   Gemma Akihiko   Taniguchi Hiroyuki   Inoue Yoshikazu   Sakai Fumikazu   Johkoh Takeshi   Fujimoto Kiminori   Kudoh Shoji  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 743-749

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer

By de Lange S.M.   van Groeningen C.J.   Meijer O.W.M.   Cuesta M.A.   Langendijk J.A.   van Riel J.M.G.H.   Pinedo H.M.   Peters G.J.   Meijer S.   Slotman B.J.   Giaccone G.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1212-1217

Elsevier

Access to resources Recommend Favorite

Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy

By Vogl Thomas   Schwarz Wolfram   Eichler Katrin   Hochmuth Kathrin   Hammerstingl Renate   Jacob Ursula   Scheller Albert   Zangos Stephan   Heller Matthias  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 11, 2006-11 ,pp. : 745-755

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic Cancer

By Kim Tae Won   Kang Hae Jin   Ahn Jin Hee   Lee Keehyun   Chang Heung Moon   Kang Yoon Koo   Lee Jung Shin  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 689-694

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer

By Song Hunho   Han Boram   Park Choong   Kim Jong   Jeon Jang   Kim In-Gyu   Kim Hyo   Jung Joo   Kim Jung   Kwon Jung   Jang Geundoo   Kim Ho   Kim Hyeong   Choi Dae   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 845-852

Springer Publishing Company

Access to resources Recommend Favorite